CBIO
CBIO
NASDAQ · Biotechnology

Crescent Biopharma Inc

Small-Cap Stocks Biotech Stocks Healthcare Stocks
$13.06
+0.12 (+0.93%)
As of Nov 7, 2:16 AM ET ·
Analyst Consensus
Strong Buy
15
Analysts
High
Coverage
Buy 13 87%
Hold 2 13%
Sell 0 0%
Price Target
Analyst Price Target +111.8% upside
Low Target $15.31
Average Target $27.66
High Target $30.74
Current Price $13.06
Current
$13.06
Target
$27.66
$15.31 $27.66 avg $30.74
Scenario Analysis
Bear Case
$15.31
17.2%
Low target
Base Case
$27.66
+111.8%
Avg target
Bull Case
$30.74
+135.4%
High target
Risk/Reward
7.9x
Highly favorable
Price in Context
52-Week High
$27.41
-52.4% from high
52-Week Low
$8.72
+49.8% from low
Target vs 52W High
$27.66
+0.9% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 39 82% $257.58 -11.6%
AMGN
Amgen Inc
 Hold 42 43% $190.87 -58.5%
GILD
Gilead Sciences Inc
 Strong Buy 37 81% $362.68 +117.3%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 82% $438.34 -19.9%
MRNA
Moderna Inc
 Hold 31 35% $149.45 -41.2%
REGN
Regeneron Pharmaceuticals
 Buy 37 70% $76.80 -91.5%
NTRA
Natera Inc
 Strong Buy 30 90% $142.91 -54.0%
RVMD
Revolution Medicines Inc
 Strong Buy 29 93% $114.11 -40.7%